Definitive Healthcare Corp. (NASDAQ:DH) Shares Bought by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA boosted its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 28.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,426,420 shares of the company’s stock after buying an additional 976,279 shares during the quarter. Massachusetts Financial Services Co. MA owned 3.75% of Definitive Healthcare worth $24,168,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Norden Group LLC acquired a new position in Definitive Healthcare during the first quarter worth about $83,000. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Definitive Healthcare by 31.4% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock valued at $116,000 after purchasing an additional 5,083 shares during the last quarter. Susquehanna Fundamental Investments LLC acquired a new stake in shares of Definitive Healthcare in the first quarter valued at approximately $120,000. Hennion & Walsh Asset Management Inc. acquired a new stake in shares of Definitive Healthcare in the second quarter valued at approximately $127,000. Finally, Principal Financial Group Inc. grew its position in shares of Definitive Healthcare by 10.8% in the second quarter. Principal Financial Group Inc. now owns 39,856 shares of the company’s stock valued at $218,000 after purchasing an additional 3,874 shares during the last quarter. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Definitive Healthcare Stock Performance

NASDAQ:DH opened at $4.50 on Friday. The company has a quick ratio of 2.40, a current ratio of 2.40 and a debt-to-equity ratio of 0.27. The company has a market cap of $530.71 million, a P/E ratio of -2.57, a P/E/G ratio of 6.38 and a beta of 1.33. Definitive Healthcare Corp. has a fifty-two week low of $3.19 and a fifty-two week high of $10.62. The firm’s 50 day moving average is $4.62 and its two-hundred day moving average is $5.87.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings results on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.09. The company had revenue of $63.70 million for the quarter, compared to the consensus estimate of $63.19 million. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. Definitive Healthcare’s revenue was up 4.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.08 earnings per share. Analysts expect that Definitive Healthcare Corp. will post 0.07 EPS for the current year.

Analysts Set New Price Targets

Several analysts have recently commented on DH shares. BTIG Research started coverage on shares of Definitive Healthcare in a research report on Tuesday. They issued a “buy” rating and a $7.00 price target on the stock. Barclays lowered their price target on shares of Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 7th. Morgan Stanley decreased their target price on shares of Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating on the stock in a research report on Tuesday, August 6th. Robert W. Baird decreased their target price on shares of Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Finally, Stifel Nicolaus decreased their target price on shares of Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating on the stock in a research report on Wednesday, July 31st. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $5.81.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.